Hibernaid
WebChief Executive Officer at Hibernaid. Stephen Petti is the Chief Executive Officer at Hibernaid based in Troy, New York. Previously, Stephen was the Chairman & Chief Executive Officer at Vital Vio and also held positions at Blue Note Pharmaceuticals, Empire Pharmaceuticals, MedEquine, DOV Pharmaceutical, Barnett International. Stephen … Web19 set 2024 · Phase 1 First-in Human randomized, open-label, active control standard of care study of the safety of HBN-1 administered as pharmacologically induced …
Hibernaid
Did you know?
WebHibernaid has 1 current employee profile, Founder and CEO Stephen J. Petti. Contacts. Edit Contacts Section. We're working on getting contact data for Hibernaid . Find more contact data in Search! Get started . Employee Profiles. Edit Employee Profiles Section. Number of Employee Profiles 1. Web8 mag 2024 · Hibernaid is developing HBN 2, a combination drug comprised of undisclosed active constituents, for oral administration in patients with progeria, mild HBN 2 - …
Web1 giu 2012 · Hibernaid, Inc. The only pharmacologically induced method to achieve Therapeutic Hypothermia. Stage Prototype Ready. Industry Biotechnology. Location … WebHBN 1 is a pharmaceutical composition of undisclosed drugs, that is being developed by Hibernaid, under a licence from the University of North Carolina, for HBN 1 - AdisInsight Either you have JavaScript disabled or your browser does not support Javascript .
WebHibernaid Inc. Naid Company Profile East Durham, NY Competitors, Financials & Contacts - Dun & Bradstreet. Find company research, competitor information, contact … WebHIBERNAID INC. NAID. Company Details. Identification, Location & Contacts This profile was last updated: 02/09/2024 Status: Expired User ID: P1831696 Name of Firm: HIBERNAID INC. NAID Trade Name ("Doing Business As ..."): DUNS Number: 071418643 Parent DUNS Number: Address, line 1: 70 COONS RD Address, line 2: City: TROY
WebHibernaid, Inc. Jan 2010 - Present 13 years 2 months. Company's lead research program HBN-1, developed at UNC-Chapel Hill, ...
WebMelisa Barron is a Director, Chemistry, Manufacturing & Controls & Formulations Development at Hibernaid based in Troy, New York. Previously, Meli sa was a Senior Scientist at Terapio and also held positions at Formex, Formex, Affinium Pharmaceuticals, Brickell Biotech, Theravance Biopharma, Viatris. jdrf christmas cardsWebHibernaid has raised a total of $100K in funding over 1 round. This was a Venture - Series Unknown round raised on Dec 22, 2024. Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 1. Total Funding Amount $100K. Hibernaid has raised a total of $100K in funding over 1 round. jdrf closed loopWebSponsor: Lead Sponsor: Hibernaid, Inc Fonte: Hibernaid, Inc Breve riassunto: Studio di fase 1 First-in Human randomizzato, in aperto, di controllo attivo standard di cura del … jdrf children\\u0027s congress 2019WebHibernaid has raised a total of $100K in funding over 1 round. This was a Venture - Series Unknown round raised on Dec 22, 2024. Funding Rounds. Edit Funding Rounds Section. … jdrf college scholarshipsWebHibernaid United States of America. Biography. Stephen J. Petti is the Company's Chief Executive Officer. He was formerly the Founder and CEO of Blue Note Pharmaceuticals, and prior to that, Empire Pharmaceuticals, acquired by a publicly traded company in 2004, where Mr. Petti went on to lead the Company's stroke program and also served as the ... jdrf charlotte ncWebHibernaid, Inc. is a corporation in Troy, New York. The employer identification number (EIN) for Hibernaid, Inc. is 270356035. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC. jdrf college scholarshipWebHibernaid Inc, Blue Note Pharmaceuticals, Inc listed there. ClustrMaps. Log In. Sign Up. 70 Coons Rd. Troy. Known Residents. Nicholas R Lacorte. Details. Age 40. Stephen J Petti. … jdrf car show